BERLATO, DAVIDE
BERLATO, DAVIDE
SIONCOV 2022 guidelines for staging canine cutaneous and subcutaneous mast cell tumors
2022 Marconato L.; Ferrari R.; Rossi F.; De Zani D.; Sabattini S.; Berlato D.; Amati M.; Martano M.; Annoni M.; Iussich S.; Bettini G.; Stefanello D.
SIONCOV 2022 guidelines for the treatment and histopathologic diagnosis of canine cutaneous and subcutaneous mast cell tumors
2022 Marconato L.; Ferrari R.; Rossi F.; De Zani D.; Sabattini S.; Berlato D.; Amati M.; Martano M.; Annoni M.; Iussich S.; Bettini G.; Stefanello D.
Histological grading of canine mast cell tumor: is two better than three?
2013 F. Scarpa; S. Sabattini; D. Berlato; G. Bettini
Radiotherapy in the management of localized mucocutaneous oral lymphoma in dogs: 14 cases.
2012 Berlato D.; Schrempp D.; Van Den Steen N.; Murphy S.
Evaluation of Minichromosome Maintenance protein 7 (MCM7) as a prognostic marker in canine cutaneous mast cell tumours.
2011 Berlato D.; Stewart J.; Newton R.; Maglennon G.; Monti P.; Flindall A.; Murphy S.
Initial evaluation of urinary Cystatin C measurement by immunoturbidimetry (PETIA) in dogs as a marker of renal tubular damage.
2011 Monti P.; Dell’Orco M.; Corte M.; Galvagni A.; Benchekroun G.; Berlato D.; Archer J.
Is Minichromosome Maintenance Protein 7 (MCM7) better than histological grade, mitotic index, or Ki-67 in predicting survival in dogs with cutaneous mast cell tumour?
2011 Berlato D.; Stewart J.; Newton R.; Maglennon G.; Monti P.; Flindall A.; Murphy S.
Outcome of oral mast cell tumour in dogs
2011 Elliott J.; Berlato D.; Grant I.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| SIONCOV 2022 guidelines for staging canine cutaneous and subcutaneous mast cell tumors | Marconato L.; Ferrari R.; Rossi F.; De Zani D.; Sabattini S.; Berlato D.; Amati M.; Martano M.; A...nnoni M.; Iussich S.; Bettini G.; Stefanello D. | 2022-01-01 | VETERINARIA | - | 1.01 Articolo in rivista | - |
| SIONCOV 2022 guidelines for the treatment and histopathologic diagnosis of canine cutaneous and subcutaneous mast cell tumors | Marconato L.; Ferrari R.; Rossi F.; De Zani D.; Sabattini S.; Berlato D.; Amati M.; Martano M.; A...nnoni M.; Iussich S.; Bettini G.; Stefanello D. | 2022-01-01 | VETERINARIA | - | 1.01 Articolo in rivista | - |
| Histological grading of canine mast cell tumor: is two better than three? | F. Scarpa; S. Sabattini; D. Berlato; G. Bettini | 2013-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Radiotherapy in the management of localized mucocutaneous oral lymphoma in dogs: 14 cases. | Berlato D.; Schrempp D.; Van Den Steen N.; Murphy S. | 2012-01-01 | VETERINARY AND COMPARATIVE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Evaluation of Minichromosome Maintenance protein 7 (MCM7) as a prognostic marker in canine cutaneous mast cell tumours. | Berlato D.; Stewart J.; Newton R.; Maglennon G.; Monti P.; Flindall A.; Murphy S. | 2011-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Initial evaluation of urinary Cystatin C measurement by immunoturbidimetry (PETIA) in dogs as a marker of renal tubular damage. | Monti P.; Dell’Orco M.; Corte M.; Galvagni A.; Benchekroun G.; Berlato D.; Archer J. | 2011-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Is Minichromosome Maintenance Protein 7 (MCM7) better than histological grade, mitotic index, or Ki-67 in predicting survival in dogs with cutaneous mast cell tumour? | Berlato D.; Stewart J.; Newton R.; Maglennon G.; Monti P.; Flindall A.; Murphy S. | 2011-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Outcome of oral mast cell tumour in dogs | Elliott J.; Berlato D.; Grant I. | 2011-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |